ASX 200 News: Vulcan, PointsBet, and CSL Updates
We examine ASX updates from PointsBet Holdings Ltd [ASX:PBH], Vulcan Energy Resources Ltd [ASX:VUL], and CSL Ltd [ASX:CSL].
ASX:CSL
CSL Share Price Spikes Higher on US$2.1 Billion Profit (ASX:CSL)
It seems even a pandemic can’t put a dampener on CSL Ltd’s [ASX:CSL] performance. The biotech superstar has defied all the odds today. Reporting a US$2.1 billion profit for the 2020 financial year. Up 17% from the year prior...
Weekly ASX Market Wrap — ANZ and Lendlease Top Movers Last Week
The past week saw the All Ords [XAO] crack the 6,000-point mark, only briefly, but it still made it through. Last week saw many companies on the market moving up in line with the broader move of the All Ords. Financials had a strong week, posting gains of 11.13%...
Could CSL Become the New Standard of Income Stocks? (ASX:CSL)
It is a little over a month since Melbourne-based biotech company CSL Ltd [ASX:CSL] officially became the largest firm on the ASX. The biotech behemoth could be poised to become a standard fixture for income investors...
RBA Rate Cuts Crowns CSL Australia’s Biggest Firm
CSL, with a market cap of $142 billion, now accounts for 8.2% of the ASX 200 Index, compared with 8.1% for Commonwealth Bank of Australia, whose market cap dropped to $140 billion as of Tuesday’s close.
ASX Blue Chip Wrap: CSL & CBA Share Price Up on Results
At time of writing, the share prices of CSL Ltd [ASX:CSL] and Commonwealth Bank of Australia [ASX:CBA] are up .82% and 2.03% respectively. CSL shares are up nearly 70% and CBA shares are up more than 17% over the last 12 months...
CSL Share Price Up 50% in a Year – Low Interest Rates Distorting the Market?
Biotech blue chip CSL Ltd [ASX:CSL] will be on watch today after the company released their Research and Development Investor Briefing. The report showed CSL’s commitment to R&D reached $832 million in the last financial year...
CSL Results Point to Healthy Dividend: But Will it Move Down with Markets?
At time of writing, shares of biotech giant CSL Limited [ASX:CSL] are trading up 4.95%, at $230.36. As a blue chip, the CSL share price has a strong proclivity to move with markets.
CSL’s Share Price Drops 2.75% on China Changes | ASX:CSL
Shares of biotech company CSL Ltd [ASX:CSL] are trading lower this morning, upon news it will be changing its distribution model. At time of writing, CSL’s share price is down 2.75% to trade at $213.32 per share.
The…
Broad-Based Gains for Blue Chips: Why the ASX Is Up Today
At time of writing, there have been broad-based gains for blue chip stocks and the ASX 200 is up 39.2 points.